arrow
M

Malwina Brożyna

Wroclaw Medical University
H指数:12
被引数:496

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Corrigendum to “Low-nanomolar chetomin in human skin cells: Preserved viability and wound closure, reduced basal IL-6 and IL-1β release, and preliminary tolerability in Galleria mellonella” [Biochem. Biophys. Res. Commun. 838, (2026), 154637]

勘误:“低纳摩尔浓度下,chetomin在人类皮肤细胞中的作用:保持细胞活力和伤口闭合,降低基础IL-6和IL-1β释放,以及<em>Galleria mellonella</em>中的初步耐受性”[Biochem. Biophys. Res. Commun. 838, (2026), 154637]

2026-10-250
PRE
Low-Nanomolar Chetomin in Human Skin Cells: Preserved Viability and Wound Closure, Reduced Basal IL-6 and IL-1β Release, and Preliminary Tolerability in Galleria mellonella

低纳摩尔量Chetomin在人体皮肤细胞中的效果:保持细胞活力和伤口闭合,降低基础IL-6和IL-1β释放,以及初步在<em>Galleria mellonella</em>中的耐受性

2026-10-010
OAAI
Potential of isoquinoline-alkaloid-rich Papaveraceae extracts against bacteria causing ocular infections – In vitro and In vivo study

富含异喹啉生物碱的罂粟科提取物对引起眼部感染的细菌的潜力——体外和体内研究

2026-08-140
OA
Design and optimization of the surfactant mixture ratio for oleic acid-based ophthalmic nanoemulsions prepared by the HPH technology - feasibility study for clotrimazole as a model drug

基于HPH技术的油酸基眼科纳米乳液中表面活性剂混合比例的设计与优化——以克霉唑为模型药物的可行性研究

2026-04-010
PRE
Octenidine Lozenges Intended for Oral Administration Display In Vitro Activity Against Oropharyngeal Pathogens and Safety Toward Intestinal Microbiota

奥替尼定含片(Octenidine Lozenges)用于口服给药,在体外显示出对口腔咽部病原体的活性,并对肠道微生物群具有安全性。

2026-03-030
OA
The Influence of Lipopolysaccharide O-Antigen Chain Length on Biofilm Formation Capacity and Outer Membrane Proteome Shape of Salmonella Enteritidis

沙门氏菌肠炎(Salmonella Enteritidis)的脂多糖O-抗原链长对其生物膜形成能力及外膜蛋白组构型的影响

2025-11-200
OAAI